MedTrace Logo

Contrast Nephropathy in Type 2 Diabetes

NCT03470454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-09-16

No results posted yet for this study

Summary

To study the effect of radiocontrast material on kidney functions in diabetics with microalbuminuria

Conditions

  • Kidney Function Affection Upon Exposure to Radiocontrast
  • Diabetes
  • Microalbuminuria

Interventions

DRUG

Linagliptin Oral Tablet

Linagliptin for blood glucose control

Sponsors & Collaborators

Principal Investigators

  • Usama A Sharafeldin, MD · Cairo University

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-09-30
Completion
2018-11-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470454 on ClinicalTrials.gov